The 2024 analysis of European production in corticosteroid medicaments reveals Denmark as a leading player with the highest value, followed by Belgium and Germany. Notable year-on-year increases occurred in Denmark (16.48%), and the Netherlands (63%), while significant declines were seen in Italy (-21.43%) and Poland (-14.65%) in 2023. Over the past five years, Denmark's consistent growth is evident, while Western and Central European countries display mixed trends.
Future trends to watch include potential market expansion in countries like the Netherlands and continued investment in innovation. Also, watch for regulatory changes and advancements in biotechnology affecting production and demand dynamics.
Top countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Denmark | 60.03 | 2023 | +10.36% | +16.48% | View data |
| 2 | 2 Belgium | 16.59 | 2023 | +3.18% | +3.69% | View data |
| 3 | 3 Germany | 7.88 | 2023 | +2.38% | +8.63% | View data |
| 4 | 4 Netherlands | 5.62 | 2023 | +37.82% | +63% | View data |
| 5 | 5 France | 3.83 | 2023 | -2.71% | -3.06% | View data |
| 6 | 6 Italy | 3.11 | 2023 | -2.55% | -21.43% | View data |
| 7 | 7 Spain | 2.29 | 2023 | +10.35% | +12.66% | View data |
| 8 | 8 Hungary | 0.79 | 2023 | +3.16% | +8.43% | View data |
| 9 | 9 Croatia | 0.73 | 2023 | +4.75% | +5.55% | View data |
| 10 | 10 Greece | 0.19 | 2023 | +5.99% | +6.44% | View data |
